General Information

Who is Attending Targeting Microbiota 2024?

Academia Sinica
Asan Medical Center
Beneficial Microbes
Copan Italia Spa
ETH Zurich
Herbalife Nutrition
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
ILVO
Institute of Human Genetics Polish Academy of Sciences
Institute of Microecology
Instituto de Investigación nutricional
IUF - Leibniz Research Institute for Environmental Medicine
IUF Düsseldorf
JHJ Sp. z o.o.
Kinderarztpraxis Arlt-Bonakdar
Laval University
Maastricht University

Masaryk university
Örebro University
PANACEA
RIKEN Center for Integrative Medical Sciences
Sidra Medicine
UGent
Università degli Studi di Milano-Bicocca
Universitat de Girona
Université de Montréal/CHUM
University Gent
University of Aberdeen
University of Guadalajara
University of Milan
University of Oulu
University of Ulm
University of Veterinary Medicine and Pharmacy
Zentiva

22/04/2024

Targeting Microbiota 2024: Confirmed Speakers

Hiroshi Ohno 1Gut Microbiome, Obesity and Diabetes
Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan
Alan WalkerHuman Microbiome Myths and Misconceptions
Alan Walker, 
University of Aberdeen, United Kindgom
Andreas Schwiertz 1Probiotics & Health: How to Select the Right Strain?
Andreas Schwiertz, Institute of Microecology, Germany
José Manuel Fernández RealGut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed
José Manuel Fernández-Real, Universitat de Girona, Spain
Pascale VonaeschTargeting Small Intestinal Microbiota: Impact on Metabolism
Pascale Vonaesch, Lausanne University, Switzerland
Justus ReunanenMicrobiota-Derived Extracellular Vesicles: Bridging Mother and Fetus
Justus Reunanen, University of Oulu, Finland
Robert JM BrummerMicrobial Therapy in Clinical Practice - From Evidence-Based Medicine towards a Personalised Approach
Robert-Jan Brummer,
 Örebro University, Sweden

Ellen BlaakMicrobial Phenotypes in Obesity: Implications for Precision Nutrition
Ellen Blaak, Maastricht University, Netherlands

Martin LoessnerPhage Therapy & Microbiome Medicine: Emerging Applications and Challenges
Martin Lössner, 
ETH Zurich, Switzerland
Koen VenemaSophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease
Koen Venema, Editor-in-chief of Beneficial Microbes, Netherlands
Rochellys Diaz HeijtzTargeting the Gut-Brain Axis: The Role of Microbiota Manipulation
Rochellys Diaz Heijtz, Karolinska Institutet, Sweden
Patrick C. H. HsiehGut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience
Patrick C. H. Hsieh, Academia Sinica, Tawian
Souhaila Al Khodor 1The Oral-Placental Microbiome Axis in Preterm Birth
Souhaila Al Khodor, Sidra Medicine, Qatar
Simone Domenico GuglielmettiGut Microbiome Signatures in Irritable Bowel Syndrome
Simone Domenico Guglielmetti, Università degli Studi di Milano-Bicocca, Italy
Christian Riedel 1From (Meta)genomes and Microbiomes and Back - Identification, Production and Application of Bacteriocins
Christian Riedel, University of Ulm, Germany

Targeting Microbiota 2024 Sessions

Day 1 - Monday, October 14, 2024

Key note Speaker: 
The Kingdom of Microbiome: Where we are now and where we are heading?  Messages & Perspectives

Session 1:
Investigating the Role of Microbiota in Health & Disease: Mechanistic Insights and Recent Developments

Session 2:
Integrating One Health Approach: Environment, Animals and Human Lifestyle Factors in Health Strategy


Day 2 - Tuesday, October 15, 2024 

Session 3:
Advancements in Microbiome Medicine: Perspective

   a. Fecal Microbiota Transplantation (FMT): Clinical Applications, Regulation and Insights

   b. Probiotics in Health & Disease Management: Strain-Specific Efficacy and Challenges

   c. Metabolites Analysis: Characterization and Synthetic Approaches for Clinical and Nutritional Research

   d. Phage Therapy: Emerging Applications and Challenges

   e. Extracellular Vesicles and Exosomes: Where is the Target?

 

Session 4: Probiotic & Prebiotic Prescribing Practices: Empowering Medical Doctors for Improved Patient Health

How Can We Integrate the Latest Research for Optimal Results?
What Are the Challenges and Opportunities in Current Probiotic Use?
How Can Next-Generation Probiotics Transform Patient Care?

This specialized workshop will target medical professionals including cardiologists, neurologists, oncologists and others.

More information.


International Society of Microbiota
Press ReleasesLinkedIn | Facebook

 Logo ISM2022 2048x931

Targeting Microbiota 2023 Replay & Abstracts Book are Available

CoverA4 TargetingMicrobiota 2023

Targeting Microbiota 2023 - Replay Access

Targeting Microbiota 2023 Recordings are now available for replay. You can get access to all recorded presentations for 3 weeks. On-demand content make it easier for you to access the presentations at your convenience. 
 
22 hours of presentations on Microbiota
62+ presentations (major talks and short orals)
 

Targeting Microbiota 2023 Abstracts Book

The 10th edition of Targeting Microbiota digital abstracts book compiles 62+ abstracts: from major talks to Short Oral and Poster Presentations. It also includes speaker details and emails for direct connections. 

Order Abstracts Book.


Targeting Microbiota 2023 Congress - Replay + Abstracts Book

You can benefit from Targeting Microbiota 2023 Recording access + Abstract Book together for a clearer vision and a better Targeting Microbiota Conference experience.

Order both abstracts book and the replay. 

 

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next